1 insider bought €8,903 of shares over the last 90 days, the latest filed 02 Sept 2026.
Navamedic ASA, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to Oslo Børs. 3 insiders have disclosed 4 filings since 18 October 2025.
No insider sold shares on the market over the period. Instead, the filings list 4 purchases totalling €64k, made by 3 insiders. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. One trade stands out by size: a purchase of €37k from Nils Ole Krekling, disclosed on 27 February 2026.
The most recent open-market purchase was published on 2 September 2026, 45 days ago.
Across the 258 companies tracked on its exchange, the median is 4 filings; at 4 filings, this issuer sits right on that mark. Since 2022, the database holds 13 purchases and 3 sales by insiders of the company.
Elsewhere in the same sector, our signals recently picked up insider purchases at Anixa Biosciences Inc and Vivos Inc. Every figure here comes from the filings published by Oslo Børs and describes the past, not future prices; it is not investment advice.
+1 other insider
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
24 of 24 declarations
Navamedic ASA is a Norwegian company focused on health and pharmaceuticals, providing pharmaceutical products and health solutions. It is listed on the Oslo Stock Exchange.
Purchases our model currently ranks for the recommendations list.
All recommendations